Literature DB >> 19603812

Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa.

Boaz Tirosh1, Nadine Khatib, Yechezkel Barenholz, Aviram Nissan, Abraham Rubinstein.   

Abstract

The need for improved specificity in the local treatment of inflammatory bowel diseases (IBD) led us to use negatively charged liposomes to target the inflamed colonic epithelium. The purpose of the present study was to elucidate the cause for our previous observations that such liposomes accumulate, preferentially, in the inflamed mucosa of rats that were induced with experimental colitis, following luminal administration. Protein analysis (tandem mass spectrometry, verified by Western blot) of inflamed mucosal specimens, extracted at pH 3, 5 and 7, revealed an increased expression of transferrin (TF) at pH 3. Histological examination indicated that the TF was located at the luminal side of the inflamed epithelium. Negatively charged (but not neutral) liposomes adhered to both commercial and mucosal TF at low pH, but not at neutral pH. Moreover, preincubation of negatively charged liposomes with TF profoundly attenuated their adherence to the inflamed mucosa of the rat colon. It is concluded that, at a low pH, typical of the colon lumen in ulcerative colitis, TF mediates specific mucoadhesion of negatively charged liposomes to the inflamed mucosa. This observation could be useful in the rational design of specific drug vehicles aimed at IBD therapy after luminal administration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19603812     DOI: 10.1021/mp9000926

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  23 in total

1.  Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine.

Authors:  Sufeng Zhang; Won Joon Cho; Amy T Jin; Lie Yun Kok; Yunhua Shi; David E Heller; Young-Ah Lucy Lee; Yixuan Zhou; Xi Xie; Joshua R Korzenik; Jochen K Lennerz; Giovanni Traverso
Journal:  Adv Healthc Mater       Date:  2020-06-29       Impact factor: 9.933

2.  IBD: selective nanoparticle adhesion can enhance colitis therapy.

Authors:  Alf Lamprecht
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06       Impact factor: 46.802

3.  Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.

Authors:  Sufeng Zhang; Robert Langer; Giovanni Traverso
Journal:  Nano Today       Date:  2017-10-09       Impact factor: 20.722

4.  Preparation, Characterization and In Vitro Evaluation of Eudragit S100-Coated Bile Salt-Containing Liposomes for Oral Colonic Delivery of Budesonide.

Authors:  Hamid Alghurabi; Tatsuaki Tagami; Koki Ogawa; Tetsuya Ozeki
Journal:  Polymers (Basel)       Date:  2022-06-30       Impact factor: 4.967

5.  An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.

Authors:  Sufeng Zhang; Joerg Ermann; Marc D Succi; Allen Zhou; Matthew J Hamilton; Bonnie Cao; Joshua R Korzenik; Jonathan N Glickman; Praveen K Vemula; Laurie H Glimcher; Giovanni Traverso; Robert Langer; Jeffrey M Karp
Journal:  Sci Transl Med       Date:  2015-08-12       Impact factor: 17.956

6.  Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease.

Authors:  Shrey Kanvinde; Yashpal Singh Chhonker; Rizwan Ahmad; Fei Yu; Richard Sleightholm; Weimin Tang; Lee Jaramillo; Yi Chen; Yuri Sheinin; Jing Li; Daryl J Murry; Amar B Singh; David Oupický
Journal:  Acta Biomater       Date:  2018-10-17       Impact factor: 8.947

Review 7.  Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases.

Authors:  Gil Aizik; Etty Grad; Gershon Golomb
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

8.  Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa.

Authors:  Efrat Harel; Abraham Rubinstein; Aviram Nissan; Elena Khazanov; Mirela Nadler Milbauer; Yechezkel Barenholz; Boaz Tirosh
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

Review 9.  Application of liposomes in drug development--focus on gastroenterological targets.

Authors:  Jian-Xin Zhang; Kun Wang; Zheng-Fa Mao; Xin Fan; De-Li Jiang; Min Chen; Lei Cui; Kang Sun; Sheng-Chun Dang
Journal:  Int J Nanomedicine       Date:  2013-04-08

10.  Encapsulation of Liposomes within pH Responsive Microspheres for Oral Colonic Drug Delivery.

Authors:  M J Barea; M J Jenkins; Y S Lee; P Johnson; R H Bridson
Journal:  Int J Biomater       Date:  2012-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.